CytomX Therapeutics, Inc.
$812.63M- Market cap
- $808.41M
- Debt
- +$16.89M
- Cash
- −$12.67M
Capital structure 98% equity / 2% debt · EV / Revenue 10.66x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
CTMX · current priceP/S 10.61x
$3.71Latest market snapshot
Implied fair value · at FN's multiple
$1.7453.2% below market
0.55 CTMX revenue / share×3.15x FN P/S=$1.74
Market $3.71Implied $1.74
FN · current priceP/S 3.15x
$407.40Latest market snapshot
Implied fair value · at CTMX's multiple
$1,373.99237.3% above market
129.51 FN revenue / share×10.61x CTMX P/S=$1,373.99
Market $407.40Implied $1,373.99